WHONET: removing obstacles to the full use of information about antimicrobial resistance.

A rich store of detailed information about antimicrobial resistance is at each medical center in paper files inaccessible to analysis or in electronic files too diverse to support a common analytical software. WHONET puts that information on a personal computer at each center in a file code and format that is the same at all centers, so that one software can then fully analyze the files at any center or those merged from many centers. The software monitors the complex matrix of interrelationships between all the measurements of resistance to antimicrobials of tested isolates of each species and of control strains. Differences at a center over time or between centers reflect differences in test performance or in the prevalence of specific resistant strains, which may be tracked. The software helps workers who are knowledgeable about resistance, infection control and clinical use of antimicrobials at any center to control test quality and integrate the management of resistance there. Their ongoing monitoring and experience locally also builds the quality and interpretation of the files merged from many centers.

[1]  J. Boyce,et al.  Spurious oxacillin resistance in Staphylococcus aureus because of defective oxacillin disks , 1988, Journal of clinical microbiology.

[2]  M. Gazouli,et al.  Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2) , 1996, Antimicrobial agents and chemotherapy.

[3]  J. P. Reardon,et al.  Molecular epidemiology of antibiotic resistance in salmonella from animals and human beings in the United States. , 1982, The New England journal of medicine.

[4]  T. O'Brien Resistance of bacteria to antibacterial agents: report of Task Force 2. , 1987, Reviews of infectious diseases.

[5]  S. Chevret,et al.  Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  N. Datta,et al.  Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era , 1983, Nature.

[7]  J. Boyce,et al.  A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. , 1990, The Journal of infectious diseases.

[8]  T. O'Brien,et al.  Detection and surveillance of antimicrobial resistance. , 1994, Trends in microbiology.

[9]  M. Syvanen,et al.  Intercontinental spread of a new antibiotic resistance gene on an epidemic plasmid. , 1985, Science.

[10]  T. O'Brien,et al.  Survey of the levels of antimicrobial resistance in Argentina: WHONET program--1991 to 1994. , 1995, International journal of antimicrobial agents.

[11]  T. O'Brien,et al.  The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. , 1990, The New England journal of medicine.

[12]  J. Boyce,et al.  Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance , 1994, Journal of clinical microbiology.

[13]  D Botstein,et al.  Dissemination of an antibiotic resistance plasmid in hospital patient flora , 1980, Antimicrobial Agents and Chemotherapy.

[14]  T. O'Brien Resistance to antibiotics at medical centres in different parts of the world. , 1986, The Journal of antimicrobial chemotherapy.

[15]  T. O'Brien,et al.  Nosocomial spread of an amikacin resistance gene on both a mobilized, nonconjugative plasmid and a conjugative plasmid , 1991, Antimicrobial Agents and Chemotherapy.

[16]  W. Schneider-Brachert,et al.  Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance , 1996, Journal of clinical microbiology.